Form 4: Promis Neurosciences Director Madge K. Shafmaster Increases Stake in Company
SEC Form 4
Director Madge K. Shafmaster reports acquiring additional common shares of Promis Neurosciences Inc. through a series of transactions.
Summary
- Madge K. Shafmaster, a director of Promis Neurosciences Inc., has reported the acquisition of additional common shares.
- On September 20, 2024, she purchased 60,000 shares at a price of $1.2511 per share.
- She continued purchasing shares on September 23, 2024, acquiring 70,000 shares at $1.2808 per share.
- On September 24, 2024, she bought another 70,000 shares at $1.3004 per share.
- Following these transactions, Ms. Shafmaster directly owns 208,333 common shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed favorably, but the scale of the purchases is not transformative.
Positives
- A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider buying is often monitored as an indicator of management's sentiment about the company's prospects, and can influence investor confidence.
Stakeholder Impact
- Shareholders may view the director's increased stake as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 09/20/2024 | Purchase of 60,000 common shares at $1.2511 per share. |
| 09/23/2024 | Purchase of 70,000 common shares at $1.2808 per share. |
| 09/24/2024 | Purchase of 70,000 common shares at $1.3004 per share. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.